Teachers Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Teachers Advisors’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.42M	Buy	51,721 +12,506	+32%	+$1.04M	0.01%	1500
2018 Q4	$2.2M	Buy	39,215 +2,139	+6%	+$131K	﹤0.01%	1790
2018 Q3	$3.03M	Buy	37,076 +9,879	+36%	+$696K	﹤0.01%	1742
2018 Q2	$951K	Buy	27,197 +6,356	+30%	+$194K	﹤0.01%	2346
2018 Q1	$427K	Buy	20,841 +154	+0.7%	+$3.96K	﹤0.01%	2599
2017 Q4	$586K	Buy	20,687 +3,568	+21%	+$99.5K	﹤0.01%	2499
2017 Q3	$532K	Buy	17,119 +1,712	+11%	+$51.5K	﹤0.01%	2558
2017 Q2	$487K	Buy	15,407 +5,291	+52%	+$130K	﹤0.01%	2609
2017 Q1	$229K	Hold	10,116	–	–	﹤0.01%	2847
2016 Q4	$221K	Buy	10,116 +1,148	+13%	+$29K	﹤0.01%	2880
2016 Q3	$236K	Hold	8,968	–	–	﹤0.01%	2815
2016 Q2	$177K	Buy	+8,968	New	+$174K	﹤0.01%	2941

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Teachers Advisors's RETA Position: Q1 2019 in Review

Teachers Advisors increased its Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) stake by 32% in Q1 2019, buying an estimated $1.04M and bringing the position to 51,721 shares worth $4.42M. The position accounts for 0.01% of the portfolio, ranked #1500.

Teachers Advisors first reported a position in RETA in Q2 2016 and has held it in 12 quarters since. 157 funds tracked by Wall St. Rank hold RETA as of Q1 2019.

Teachers Advisors held 51,721 shares of Reata Pharmaceuticals, Inc. Class A Common Stock worth $4.42M as of Q1 2019.
Teachers Advisors bought 12,506 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2019, an estimated $1.04M.
Reata Pharmaceuticals, Inc. Class A Common Stock made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1500 holding.
Teachers Advisors first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and has held it in 12 quarters since.
157 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.